BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21465955)

  • 1. Atrial fibrillation, is warfarin the only option for stroke prevention?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrial fibrillation, is warfarin the only option for stroke prevention?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Apr; 61(4):406-7. PubMed ID: 21465988
    [No Abstract]   [Full Text] [Related]  

  • 3. The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.
    Hart RG
    Int J Stroke; 2011 Jun; 6(3):207-8. PubMed ID: 21557805
    [No Abstract]   [Full Text] [Related]  

  • 4. Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation: the ACTIVE W trial.
    DeSilvey DL
    Am J Geriatr Cardiol; 2006; 15(5):326-7. PubMed ID: 16957455
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 6. Good old warfarin for stroke prevention in atrial fibrillation.
    Verheugt FW
    Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
    Meinertz T
    Internist (Berl); 2007 Aug; 48(8):874-5. PubMed ID: 17628764
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 9. Who is ineligible for warfarin in atrial fibrillation?
    Verheugt FW
    Lancet; 2009 Aug; 374(9689):510-1. PubMed ID: 19683630
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
    Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
    ; Connolly S; Pogue J; Hart R; Pfeffer M; Hohnloser S; Chrolavicius S; Pfeffer M; Hohnloser S; Yusuf S
    Lancet; 2006 Jun; 367(9526):1903-12. PubMed ID: 16765759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D; Bhuriya R; Arora R
    Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
    ; ; Connolly S; Yusuf S; Budaj A; Camm J; Chrolavicius S; Commerford PJ; Flather M; Fox KA; Hart R; Hohnloser S; Joyner C; Pfeffer M; Anand I; Arthur H; Avezum A; Bethala-Sithya M; Blumenthal M; Ceremuzynski L; De Caterina R; Diaz R; Flaker G; Frangin G; Franzosi MG; Gaudin C; Golitsyn S; Goldhaber S; Granger C; Halon D; Hermosillo A; Hunt D; Jansky P; Karatzas N; Keltai M; Lanas F; Lau CP; Le Heuzey JY; Lewis BS; Morais J; Morillo C; Oto A; Paolasso E; Peters RJ; Pfisterer M; Piegas L; Pipillis T; Proste C; Sitkei E; Swedberg K; Synhorst D; Talajic M; Trégou V; Valentin V; van Mieghem W; Weintraub W; Varigos J
    Am Heart J; 2006 Jun; 151(6):1187-93. PubMed ID: 16781218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trials of newer approaches to anticoagulation in atrial fibrillation.
    Cooper HA
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():27-31. PubMed ID: 14739737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
    Lip GY; Lane DA
    Am J Med; 2010 Sep; 123(9):785-9. PubMed ID: 20655037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 18. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 19. Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
    Fabiaña N; Ramaswami AP; Ang ES; De Silva DA
    Ann Acad Med Singap; 2015 Jul; 44(7):266-8. PubMed ID: 26377061
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.